INTECH Investment Management’s AtriCure ATRC Stock Holding History

INTECH Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$296K	Sell	10,584 -442	-4%	-$12.4K	﹤0.01%	1589
2026 Q1	$315K	Sell	11,026 -6,701	-38%	-$229K	﹤0.01%	1556
2025 Q4	$701K	Sell	17,727 -2,498	-12%	-$91.6K	0.01%	1329
2025 Q3	$713K	Sell	20,225 -8,741	-30%	-$301K	0.01%	1380
2025 Q2	$949K	Sell	28,966 -2,743	-9%	-$89.1K	0.01%	1224
2025 Q1	$1.02M	Buy	31,709 +10,189	+47%	+$378K	0.01%	1183
2024 Q4	$658K	Buy	21,520 +6,306	+41%	+$203K	0.01%	1406
2024 Q3	$427K	Buy	+15,214	New	+$375K	﹤0.01%	1314

Other funds holding ATRC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

INTECH Investment Management's ATRC Position: Q2 2026 in Review

INTECH Investment Management reduced its AtriCure (ATRC) stake by 4% in Q2 2026, selling an estimated $12.4K and leaving 10,584 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

INTECH Investment Management first reported a position in ATRC in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.02M in Q1 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

INTECH Investment Management held 10,584 shares of AtriCure worth $296K as of Q2 2026.
INTECH Investment Management sold 442 AtriCure shares in Q2 2026, an estimated $12.4K.
AtriCure made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1589 holding.
INTECH Investment Management first reported a position in AtriCure in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's AtriCure position peaked at $1.02M in Q1 2025.
251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.